Suarez, Catherine L.

HRN: 23-90-75  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/29/2023
CEFUROXIME 1.5GM (VIAL)
10/30/2023
10/30/2023
IVT
1.5g
On Call To OR ANST
AUB Rule Out Endometrial Pathology; Bilateral ONG; Hypertension Stage II; G2P1 (1010)
Waiting Final Action 
10/30/2023
CEFUROXIME 500MG (TAB)
10/30/2023
11/06/2023
PO
500mg
BID X 7 Days
S/P D & C
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: